REG - Indivior PLC - Transaction in Own Shares

IndiviorAnnouncement

08/10/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241008:nRSH2602Ha&default-theme=true

RNS Number : 2602H  Indivior PLC  08 October 2024

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

October 8, 2024

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total
of 391,693 of its ordinary shares of $0.50 each through Morgan Stanley &
Co. International Plc in the period from September 30, 2024, up to and
including October 4, 2024, in connection with its $100m Share Repurchase
Program. Aggregated information on the purchase of these shares can be found
in the table below.

Following the purchase and cancellation of the above shares (including those
purchased but not yet settled), Indivior has 129,223,204 ordinary shares of
$0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (129,223,204) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or a change
to their interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is
defined in the rules of the London Stock Exchange) and "on market" for the
purposes of the Companies Act 2006.

Aggregated information

 Trading Date  Trading Venue  Aggregated daily volume (number of shares)  Daily weighted average purchase price of the shares (p)
 30/09/2024    LSE            26,749                                      737.06
 30/09/2024    BATE           2,840                                       736.89
 30/09/2024    CHIX           8,283                                       736.92
 30/09/2024    AQUIS          1,820                                       737.07
 01/10/2024    LSE            40,899                                      724.71
 01/10/2024    BATE           9,297                                       724.68
 01/10/2024    CHIX           38,008                                      725.13
 01/10/2024    AQUIS          3,157                                       727.11
 02/10/2024    LSE            42,209                                      748.81
 02/10/2024    BATE           11,913                                      749.25
 02/10/2024    CHIX           34,104                                      750.22
 02/10/2024    AQUIS          6,257                                       746.59
 03/10/2024    LSE            41,446                                      752.78
 03/10/2024    BATE           11,928                                      752.34
 03/10/2024    CHIX           32,573                                      751.74
 03/10/2024    AQUIS          5,011                                       751.26
 04/10/2024    LSE            37,339                                      765.72
 04/10/2024    BATE           8,790                                       769.38
 04/10/2024    CHIX           22,473                                      767.72
 04/10/2024    AQUIS          6,597                                       762.01

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation
(EU) No 596/2014, as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary shares
made by Morgan Stanley & Co. International Plc on behalf of Indivior
during the above period as part of the Share Repurchase Program can be found
at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program
(http://www.indivior.com/en/investors/shareholder-information/share-repurchase-program)
.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSZZMGGRNZGDZM